Satoreotide
Satoreotide (JR11) is a SSTR2 antagonist. Satoreotide is usually conjugated with radiolabeled chelators used in neuroendocrine tumor imaing[1].
Product Specifications
CAS Number
[1801415-23-5]
Product Name Alternative
JR11
UNSPSC
12352209
Target
Radionuclide-Drug Conjugates (RDCs) ; Somatostatin Receptor
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related; GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/satoreotide.html
Purity
98.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C([C@@H](NC([C@@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@@H](C(N)=O)CC2=CC=C(C=C2)O)=O)NC([C@@H](N)CC3=CC=C(C=C3)Cl)=O)=O)CC4=CC=C(C=C4)NC([C@@H]5CC(NC(N5)=O)=O)=O)N[C@@H]1CC6=CC=C(C=C6)NC(N)=O
Molecular Formula
C58H72ClN15O14S2
Molecular Weight
1302.87
References & Citations
[1]Kersting D, et al. 68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer Patients[J]. 2023.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Phase 2
Isoform
SSTR2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx455957-01 50 µg
5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha 1 (PRKAA1) Antibody
Ask
View Details abx455957-02 100 µg
5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha 1 (PRKAA1) Antibody
Ask
View Details 
GTR15240685 1 Vial
Lentiviral mouse Htr1a shRNA (UAS) - Lentiviral mouse Htr1a shRNA (UAS, RFP) plasmid
Ask
View Details 
